The Boston Scientific Coyote Balloon Catheter (REF H74939186352210) is a low-profile, over-the-wire percutaneous transluminal angioplasty (PTA) balloon catheter configured with a 3.5 mm balloon diameter and 220 mm balloon length. Engineered for peripheral vascular procedures, the Coyote platform is designed to deliver predictable balloon performance through tortuous and challenging anatomy.
Key Features
- Low-profile balloon design intended to facilitate crossing of tight or tortuous lesions
- Over-the-wire (OTW) configuration compatible with 0.014 inch guidewire systems
- Long 220 mm working balloon length for treatment of extended lesion segments with fewer balloon exchanges
- Hydrophilic coating on the distal shaft to support trackability and deliverability
- Radiopaque markers to assist fluoroscopic balloon positioning
- Compliant with standard inflation device workflows; refer to IFU for nominal and rated burst pressures
Clinical Applications
- Peripheral transluminal angioplasty in select vessels as described in the manufacturer Instructions for Use
- Dilatation of stenoses to improve luminal flow in peripheral arteries
- Post-dilatation following stent placement where appropriate per operator discretion and IFU
- Suitable case selection and indication scope must follow the official Boston Scientific IFU and applicable local regulations
Product Information
Brand: Boston Scientific
Product Family: Coyote Balloon Catheter
Category: Peripheral Balloon Catheters (PTA)
Balloon Diameter: 3.5 mm
Balloon Length: 220 mm
Catheter Type: Over-the-wire PTA balloon catheter
Guidewire Compatibility: 0.014 inch (per Coyote platform specifications)
Usable / Working Length: Not specified in the located sources
Sheath Compatibility: Not specified in the located sources
Nominal / Rated Burst Pressure: Not specified in the located sources
Sterility: Supplied sterile for single use; do not resterilize
REF / UPN: H74939186352210
Storage: Store per manufacturer labeling, away from direct sunlight and extreme temperatures
Note: All clinical use, indications, contraindications, warnings and precautions must follow the official Boston Scientific Coyote Instructions for Use and applicable regulatory clearances in the destination market.